Business Context and Reporting Period
This Form 8-K Current Report was filed by Disc Medicine, Inc. (Nasdaq: IRON) on October 6, 2025, covering events occurring on October 3, 2025. The filing addresses a change in the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
On October 3, 2025, Mona Ashiya, Ph.D., resigned from the Board of Directors, effective immediately. Dr. Ashiya was a Class I director and served on the Compensation Committee and the Nominating and Corporate Governance Committee. Consequently, she also resigned from these committees. The Board size was reduced from nine members to eight. The Company stated that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies were disclosed in this report other than the standard disclosure regarding the director's departure.
Key Facts for Investor Verification
- Dr. Mona Ashiya resigned from the Board and all committee assignments effective October 3, 2025.
- The Board of Directors now consists of eight members.
- The Company explicitly stated there was no disagreement between the departing director and the Company.
- Investors should verify if the Company intends to fill the vacancy on the Board or reconstitute the affected committees.